Proud to be supporting the EDIS initiative. Join our Clinical Development Operations Leader, Peju Oshisanya on 9th September where she'll be discussing the importance of diversity in clinical trials and AI
Nathan Brown, Head of Cheminformatics at BenevolentAI will be presenting at the Medicinal Chemistry Symposium in Cambridge on Optimising Multiobjective Molecular Design, join us.
Joshua Meyers, Cheminformatics Data Scientist at BenevolentAI will be presenting at the Royal Society of Chemistry on our latest paper: DeeplyTough: Learning to structurally compare protein binding sites. Reach out!
Marwin Segler, Machine Learning Researcher at BenevolentAI will be giving a talk on using machine learning to address challenges in Computer-Assisted Automated Synthesis Planning (CASP) at RICT 2019.
Bryn Williams-Jones, Director of Exploratory Research at BenevolentAI will be participating to a panel discussion around AI in Life Sciences at the Elixir Bioinformatics Supplier Forum
Mark Rackham, VP Chemistry at BenevolentAI will be giving a talk at the “Hatfield MedChem" meeting this spring! More info
Andrea Taddei, Mechanistic Area Lead at BenevolentAI will be presenting at Elrig event on Artificial Intelligence - From Data to Drugs. This presentation will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases. We will highlight where progress has been fast and where challenges (for example, data availability) still remain, making subtle, well placed reference to how we are doing this along the way.
Nathan Brown, Head of Cheminformatics at BenevolentAI will be participating to a discussion at the Francis Crick Institute around “the challenges preventing Cancer cure”
Join Alix Lacoste VP Data Science and Michelle Gill, Senior Data Scientist at BenevolentAI for a presentation on "Machine Learning for Target Identification and Lead Optimization in Drug Discovery".
Join Ian Churcher, SVP Drug Discovery at BenevolentAI for a talk on Artificial Intelligence - From Data to Drugs at the Royal Society of Medicine. Ian will give an overview of the various ways that AI is being applied to find new uses for existing drugs, as well as finding novel treatments for diseases.
Join Joanna Shields, CEO at BenevolentAI for a speech at the Digital-Life-Design conference in Munich. DLD stands for Digital, Life, Design and explores how the digital age fundamentally changes our lives, society and business.
Join Joanna Shields, CEO at BenevolentAI for a keynote at the JP Morgan Healthcare Conference. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community
Join Joanna Shields, CEO BenevolentAI, Robert Nelsen, Co-Founder & Managing Director, ARCH Venture Partners and Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation at The Forbes Healthcare Summit for a panel on How Smart Is Artificial Intelligence
Join Daniel Swerlow, Drug Discovery Physician at BenevolentAI for a talk on Discovering drugs in the growing pool of OMICS - a role for AI
Join Nathan Brown at the German Conference on Cheminformatics in Mainz to discuss In silico molecular design
Join Mark Davies at Global Engage congress on pharmaceuticals research & development. Mark Davies will present on how Artificial Intelligence (AI) is disrupting drug discovery.